The new product reinforces Meridian’s leadership in enzyme stabilization and enables simplified and decentralized Next-Generation-Sequencing sample preparation. CINCINNATI--(BUSINESS WIRE)--The Life ...
Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that Health Canada has granted a license for its Alethia® CMV assay ...
Ambient-stable NGS workflows, enabled by Meridian's lyophilization expertise, expand global access to 4bases' KaryoSolver™*, a platform for rapid structural variant analysis CINCINNATI, June 10, 2026- ...
CINCINNATI, Dec. 12, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced that it has ...
The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of two new immunoassay ...
Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, today announced that a broad portfolio of its Alethia molecular assays has ...
Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that the United States Food and Drug Administration (FDA) has ...
Ambient-stable NGS workflows, enabled by Meridian’s lyophilization expertise, expand global access to 4bases’ KaryoSolver™*, a platform for rapid structural variant analysis The Life Science division ...